The triterpenoid, lupeol (1) has been isolated from the leaves extract of Walsura trifoliate. Few novel derivatives (4a-j) were synthesized from the naturally occurring lupeol (1) and confirmed by spectroscopic methods, and tested for antimicrobial and anti-proliferative activity against MDAMB-231, IMR32and A549 cell lines. This all compound showed moderate activities.
INTRODUCTION
Triterpenoids are secondary metabolites derived from plants, fungi etc. triterpenoids contain about thirty carbon atoms, and their structures are considered to be derived from the acyclic precursor squalene 1 . Triterpenes are widely distributed in nature; more than 20,000 triterpenoids has been isolated from Nature, which belong to different groups such as squalene, lanostane, dammarane, lupane, oleanane, ursane, hopane, etc. 2 . Among these triterpenoids, lupane has attracted much attention due to their broad spectrum of biological activities.
The genus Walsura Roxb. (Meliaceae) is a rich source of triterpenoids 3 with promising biological activities. Walsura trifoliata (synonym: Walsura piscidia Roxb.) is distributed widely in the tropical areas of China, India, Malaysia, and Indonesia. These are well known for their medicinal properties like treatment of skin allergies, astringency antimicrobial activity and diarrhea 4 . Walsura trifoliate is a new source of Lupeol and we first time isolated from leaves through chloroform extract.
Lupeol (1) is a lupane type pentacyclic triterpene is principally found in common fruit plants such as olive, mango, plant, fungi etc. 5 . Lupeol exhibit an array of pharmacological activities against various diseases include anti-inflammation 6 , anti-arthritis 7 , anti-oxidant 8, 9 , anti-tuberculosis 10 , diabetes, cardiovascular ailments, anti HIV 11 , hepatic toxicity, microbial infections and cancer 12 . The literature also suggests that lupeol significantly reduced the growth of human PaC tumors and regulates over expression of cellular FLICE-like inhibitory protein (cFLIP) 13 , modulates NF-jB and PI3K/Akt pathways and inhibits skin cancer 14 . In recent years there has been rapid progress in the field of derivitization of natural products with the increase in biological activity than the parent molecule. Thus the synthesis of lupeol and its ester on cyclophosphamideinduced hyperlipidaemic cardiomyopathy protection to the cardiac tissue , could preserve membrane permeability 15 could preserve lysosomal integrity, improve thiol levels 16 . Lupeol and their ester derivatives show anti-diabetic 17 , anticancer, antiinflammatory 18 , hypercholesterolemia 19 etc. Very few oxime derivatives have been reported. This motivated us to study the biological properties of oxime ester derivatives of lupeol.
By analyzing Lupeol, the OH group at C-3 position can be modified for the synthesis of oxime derivatives. In continuation of our interest on synthesis of derivatives of biologically active natural products, we report synthesis of series of oxime ester derivatives (4a to j) from natural product Lupeol.
MATERIALS AND METHODS

Experimental
All the solvents were dried by using drying agents and distilled prior to use. The reagents were purchased from Aldrich and Across and were used without purification unless otherwise stated. All moisture-sensitive reactions were carried out under nitrogen condition. Silica gel (Acme 60-120 mesh) was used for Column chromatographic separations. 
Isolation of lupeol from Walsura trifoliate
Lupeol was isolated for the first time form
Walsura trifoliata. The fresh leaves of Walsura trifoliate were collected and shade dried for 48 hrs and coarsely powdered. About 1 kg powdered leaves was taken into RBF and extracted with chloroform using soxlet apparatus for 12 hrs. The resultant extract was dried and purified using column chromatography.
Synthesis of oxime ester derivatives of Lupeol (4a-j)
Step 1
Synthesis of lupeol ketone intermediate (2)
Exactly weighed 1 gm of Pyridinium chlorochromate (PCC) (2.34 mmol) was added to solution containing 75 mg of lupeol (1) (3.52 mmol) dissolved in 5 mL DCM. Stirr the reaction mixture at room temperature for 3 h and 10 mL of isopropanol was added slowly. The reaction mixture is kept again for stirring continuously at room temperature until the reaction is completed (TLC). After completion of reaction the excess of solvent was removed under reduced pressure. In order to separate the analogues from organic compounds, the residue was triturated with ether and the organic layer was separated. Then the separated organic layer was washed with 1M HCl followed by 10 ml of brine solution. The resulting mixture was concentrated and the crude obtained was purified by column chromatography using EtOAC/Hexane (1:9) to give pure compound (2) (yield: 842 mg, 85%).
Step: 2
Synthesis of lupeol oxime intermediate (3)
Exactly weighed 0.54 gms of above synthesised compound (2) and 0.13 gms of hydroxylamine hydrochloride were taken in 5 ml of dry pyridine and refluxed for 1 hr. the reaction was monitored using TLC. After cooling, the reaction mixture was poured onto crushed ice and extracted using ethyl acetate. The resulting organic layer was concentrated and the crude product was purified by using column chromatography with EtOAC/Hexane (2:8) to give pure compound (3) (Yield: 684 mg, 80%).
Step-3 Synthesis of lupeol oxime ester derivatives
Exactly weighed 20 mg of compound (3), 17 mg of substituted aromatic acids are mixed in 2 mL of dry THF to this mixture 33.56 µml of Et 3 N was added and stirred for 0.5 h at room temperature. To this solution 17.74 µml of 2, 4, 6-trichlorobenzoyl chloride in 2 mL dry THF was added and stirring was continued for 5 h at room temperature the reaction was monitored by TLC. The solvent was evaporated and the remaining residue was diluted with 2mL of toluene followed by catalytic amount of DMAP and finally with oxime alcohol 3 (660 mg, 1.50 mmol) and stirred for 14 h at room temperature. Toluene was evaporated and crude residue purified by column chromatography EtOAC/Hexane (1:9) to give pure compound KSB-1 (53 mg, 82%). 3aR, 5aR, 5bR, 11aR, E)-3a, 5a, 5b, 8, 8,  11a -hexamethyl -1 -(prop -1 -en -2 -yl (1R, 3aR, 5aR, 5bR, 11aR, E)-3a, 5a, 5b, 8, 8, 11a-hexamethyl-1-(prop-1-en-2-yl) (1R, 3aR, 5aR, 5bR, 11aR, E)-3a, 5a, 5b, 8, 8, 11a-hexamethyl-1-(prop-1-en-2-yl) (1R,3aR,5aR,5bR,11aR,E)-3a,5a,5b,8,8,11a-hexamethyl-1-(prop-1-en-2-yl) (1R,3aR,5aR,5bR,11aR,E)-3a,5a,5b,8,8,11a-hexamethyl-1-(prop-1-en-2-yl) (1R, 3aR, 5aR, 5bR, 11aR, E)-3a, 5a, 5b, 8, 8, 11a 3aR, 5aR, 5bR, 11aR, E)-3a, 5a, 5b, 8, 8, 11a-hexamethyl-1-(prop-1-en-2-yl) 
RESULTS AND DISCUSSION
The synthetic route to oxime ester derivatives conjugated at the C-3 position of Lupeol 1 which was isolated from Walsura trifoliate 22 is outlined in Scheme 1. The Lupeol 1 was reacted with PCC in DCM followed by treatment with hydroxyl amine hydrochloride gave the oxime compound 3. The oxime 3 was derivatized with different acids using 2,4,6-trichloro benzoyl chloride, triethyl amine, DMAP under yamaguchi etherification conditions 1  100  150  75  150  150  150  2  75  100  50  100  75  50  3  25  75  75  150  150  150  4a  150  100  100  150  150  150  4b  50  75  50  150  110  100  4c  100  100  100  150  150  150  4d  75  150  150  100  75  150  4e  100  100  75  100  150  75  4f  150  100  100  75  150  150  4g  100  150  100  150  150  150  4h  75  50  50  25  100  50  4i  100  150  150  150  150  150  4j  150  75  100  100  75 
Anti-proliferative activity of Lupeol and its derivatives
The invitro anti-proliferative activity of isolated lupeol and its derivatives were examined against the cell lines-MDAMB-231(breast cancer), IMR32 (neuroblastoma) and A549 (lung cancer) following standard protocol 23 . The reference standard used for the antiproliferative activity was Doxorubicin which was expressed as GI 50 values (Growth inhibition 50 % ìg/mL) the results were tabulated in table-3. The results revealed that some of the synthetic analogues were exhibited promising anticancer activity when compared their parent isolated compound. Among the tested compounds, compound 3 showed good activity 20.8±0.09 (IMR 32). While compounds 4e, 4f &4h showed moderate activities with GI 50 values of 28.7±0.2, 22.4±0.09 & 27.5±0.4 /mL respectively. It is important to mention that all the tested compounds were not active against IMR 32, MDAMB-231, and A549 Cell lines. Different substitutions on the aromatic ring, derivatives affect the activity. Though it is difficult to discuss the structure activity relationship criteria responsible for anti-proliferative activity in this set of compounds
CONCLUSION
In conclusion, synthesis of series of oxime ester derivatives from natural product Lupeol has been achieved using PCC oxidation, oxime formation followed by yamaguchi etherification. These Synthesized derivatives can be screened for their antimicrobial and anti-proliferative activity studies. All the compounds showed the modatare actives.
